Search results
AstraZeneca withdrawing Covid vaccine, months after admitting rare side effect
The Telegraph via Yahoo News· 2 hours agoThe Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 5 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected...
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoModerna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 5 days agoModerna experienced a substantial financial shift in the first quarter (Q1) of 2024, reporting a net loss of $1.2bn - a stark contrast to its net income...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 5 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 5 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 5 days agoWithin minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 5 days agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 ...
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 6 days agoSouth African officials said that the decision to give a three-year contract to Indian generic...
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 8 hours agoI'll close on CF with VX-522, our CFTR mRNA therapy in development with our partners at Moderna for the treatment of the more than 5,000 people with CF who do not make any ...